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croorganisms. With consideration of antimicrobial activity 
and cytotoxic effect, OCT corresponds better to a biocom-
patible antiseptic agent than CHG. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Reconstructed human epidermis (RHE) equivalents 
have been adapted as an in vitro alternative to replace 
animal experiments, especially in the field of evaluating 
cosmetics. RHE equivalents such as skin pharmacologi-
cal models have been successfully applied to in vitro 
characterization of skin barrier functions  [1–3] , skin ab-
sorption processes  [4, 5] , drug metabolism  [6] and cor-
rosion/irritation predictions  [7–10] . Validated models 
are commercially available as EpiSkin ® (SkinEthic Labo-
ratories, France), EpiDerm ® (MatTek Cooperation, 
USA), and EST-1000 (Cell Systems, Germany)  [11] but 
also in-house models have been utilized  [12–14] for the 
assessment of in vitro skin corrosion of chemicals. Excel-
lent reviews have been published to allow correct classi-
fication of corrosive chemicals and those likely to be se-
vere irritants  [10, 15, 16] . In vitro evaluations of skin sen-
sitivity of antiseptic agents using RHE models are 
relatively rare  [13] , although these substances can dam-
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 Abstract 
 The objective of the present investigation was to examine 
the residual antimicrobial activity after a topical exposure of 
reconstructed human epidermis (RHE) to equimolar solu-
tions of either chlorhexidine digluconate (CHG, 0.144% w/v) 
or octenidine dihydrochloride (OCT, 0.1% w/v) for 15 min. 
RHE-associated antiseptic agents were more effective on 
 Staphylococcus aureus than on  Pseudomonas aeruginosa . 
 S. aureus was not detected after 24 h of contact, which dem-
onstrated a microbicidal efficacy of greater than 5-log 10 re-
duction. In contrast,  P. aeruginosa was reduced by approxi-
mately 2 log 10 at the same incubation time, which parallels 
the growth of the initial inoculum. This result could be inter-
preted either as a microbiostatic effect or as an adherence 
of   P. aeruginosa to a low positively charged surface. Small 
amounts of CHG and OCT can penetrate the stratum corne-
um. Using these antiseptic agents, the viability of keratino-
cytes was reduced to 65–75% of that of the untreated RHE 
control following 24 h incubation in the presence of test mi-
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age basal keratinocytes after having been topically ap-
plied in excess. The main task of an antiseptic agent is to 
destroy or inhibit the growth of microorganisms in or on 
living tissue  [17] . Cytotoxic effects on mammalian cells 
are usually accepted because the injured tissues can re-
generate within a few days. However, prophylactic or 
therapeutic antiseptic treatment of skin might cause the 
antiseptic agent to adhere to the stratum corneum. The 
produced high density of cationic charges topically pres-
ent may be responsible for a residual antimicrobial activ-
ity on skin similar to the one found after disinfecting 
hands with chlorhexidine-containing preparations  [18] . 
On the other hand, superficially attached cationic, posi-
tively charged substances with low charge density may be 
responsible for a preferential adherence of the negatively 
charged bacteria.
 Similar to surfactants, the antiseptic agent may be ac-
countable for removing and damaging the protective bar-
rier of the stratum corneum  [19] . Thus, it can enhance the 
diffusion of the antiseptic agent into the epidermis, re-
sulting in cytotoxic effects on keratinocytes.
 Utilizing our in-house model of RHE, we started in-
vestigating a residual antimicrobial effect on the test mi-
croorganisms,  Pseudomonas aeruginosa and  Staphylococ-
cus aureus , after applying equimolar concentrations of 
either chlorhexidine digluconate (CHG) or octenidine di-
hydrochloride (OCT). Further, the resulting irritation 
potency was evaluated and the biocompatibility of the 
two antiseptic agents was deduced from assays of cytotox-
icity and microbicidal activity.
 Materials and Methods 
 Cell Culture 
 Normal adult human keratinocytes were purchased from Pro-
moCell (C-12003, lot: 0012601.2) and for the reconstruction of the 
epidermis second- to third-passage proliferating keratinocytes 
were used. Keratinocyte growth medium KGM-2 (PromoCell, 
C-20011) was applied. It was completed with the attached supple-
ment mix (PromoCell, C-39016) resulting in final concentrations 
of 0.004 ml/ml bovine pituitary extract, 0.125 ng/ml recombinant 
human epidermal growth factor, 5 μg/ml recombinant human in-
sulin, 0.33 μg/ml hydrocortisone, 0.39 μg/ml epinephrine, 10 μg/
ml human transferrin and 0.06 m M CaCl 2 . Proliferating keratino-
cytes were harvested by trypsinization at a confluence of maxi-
mally 80–90% using a detach kit for human primary cells (Promo-
Cell, C-41220).
 Production of RHE and Validation 
 RHE equivalents were produced in 12-mm-diameter Milli-
cell-PCF polycarbonate culture inserts (0.63 cm 2 growth area) 
with 0.4-μm-diameter pore size (Millipore, PIHP01250), essen-
tially as described by Poumay et al.  [14] with minor modifica-
tions. 150–200 μl EpiLife medium (Invitrogen, Cascade Biolog-
ics, M-EPI-500-CA), supplemented with HKGS (Invitrogen, 
Cascade Biologics, S-001-5) containing 3 × 10 5 keratinocytes 
were seeded into each culture insert, which had been placed into 
6-well culture plates (TPP, Biochrom) prefilled with 1 ml of the 
same medium. After 24 h of incubation at 37  °  C in a humidified 
atmosphere with 5% CO 2 in air, the media in inserts were substi-
tuted by 0.5 ml of fresh medium, and simultaneously 0.5 ml 
of  fresh medium was added into each well. The medium was 
changed the next day. On day 3 of culture, the keratinocytes were 
exposed to the air-liquid interface by removing the medium of 
the inserts. In the 6-well culture plates, 1.5 ml of EpiLife medium 
containing HKGS, 1.5 m M CaCl 2 , and 50 μg/ml ascorbic acid 
were added to each well to feed the cells only from the bottom of 
the polycarbonate filter. The modified EpiLife medium was then 
changed every 2 days and the air-lift culture was continued for 
another 14 days to obtain culture models with characteristics of 
epidermis demonstrating the four different stratified layers  [19] . 
All cell culture media were used without antibiotics to avoid pos-
sible interactions.
 RHE samples were topically exposed to 1% Triton X-100 (pos-
itive control) and PBS (negative control) for 1–3 h. The required 
time of exposure to reduce the viability of keratinocytes to 50% of 
that of control was determined for each setup of RHE and amounts 
to 2.5–3 h.
 Measurement of Residual Antimicrobial Effect 
 OCT (0.5 ml of 0.1%, 1.6 m M, Schülke & Mayr, lot: 1170700) 
or CHG (0.144%, 1.6 m M, Sigma, C9394) were applied topically to 
the RHE for 15 min at room temperature. Sterile water was used 
as negative control. After incubation, the control and antiseptic 
solution were completely removed and the tissue surface was 
washed 5 times with 0.5 ml of sterile balanced salt solution, each 
time interrupted by carefully drying the tissue surface using a ster-
ile cotton tip swab.
 The test microorganisms,  P. aeruginosa (ATCC 15442) and  S. 
aureus (ATCC 6538), were adjusted to 10 6 colony-forming units 
(CFU)/ml in Eagle minimal essential medium with Earle’s salts 
with 10% fetal bovine serum; 0.5 ml bacterial dispersion was ap-
plied to the pretreated and washed tissue surface. Incubation up 
to 4 h was carried out in 24-well culture plates at room tempera-
ture in a humidified atmosphere. For 24 h of incubation the inserts 
were transferred back into 6-well plates containing culture me-
dium. As an additional negative control, 1 ml of test microorgan-
isms per well without RHE was used. Incubation was performed 
in two different test setups for each microorganism. Microbicidal 
effect was determined after either 15 or 30 min and either 15 min 
or 24 h for  Staphylococcus aureus , and after either 2 or 4 h and ei-
ther 2 or 24 h for  P. aeruginosa . After the demanded incubation 
time, 0.1 ml of the incubation mix was transferred into 0.9 ml of 
the inactivator solution TSHC (3% tween 80, 3% saponin, 0.1% 
 L -histidine and 0.1%  L -cysteine) for  P. aeruginosa or TSLS (4% 
tween 80, 3% saponin, 0.4% lecithin from soy bean and 1% sodium 
dodecyl sulfate) for  S. aureus . The validation of the inactivation 
mixtures of either TSHC or TSLS on CHG and OCT was addition-
ally verified in separate experiments. After 5 min inactivation, se-
rial dilutions were prepared in the inactivator and 0.1 ml of each 
dilution was plated in triplicate on Trypticase soy agar. The CFU 
of the test microorganisms were counted after 48 h of incubation 
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at 37   °   C. The log 10 microbicidal reduction value for each contact 
time was calculated according to the formula:
 log 10 microbicidal reduction value = log 10 n c – log 10 n d 
 where n c is the number of CFU of viable cells in the inoculum after 
contact with the RHE treated with sterile water and n d is the num-
ber CFU of viable cells in the inoculum after contact with the RHE 
treated with the antiseptic agent.  
 All experiments were repeated at least 3 times.
 Measurement of Viability of Keratinocytes in RHE 
 After removing the test microorganisms the tissue inserts were 
rinsed from the inside with 5 × 0.5 ml sterile balanced salt solu-
tion, carefully dried with a sterile cotton tipped swab and trans-
ferred into 24-well culture plates containing 0.5 ml (0.5 mg/ml) 
preincubated MTT. The MTT [3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide] tests  [20] have been standard-
ized for RHE  [8] . Incubation was exactly for 3 h at 37  °  C. The MTT 
medium was gently removed and the RHE was rinsed at least 3 
times with 2 ml PBS and dried carefully with cellulose swabs. Tis-
sue inserts were embedded in 2 ml extractant solution (0.04  M HCl 
in propan-2-ol) for overnight incubation at 4  °  C in the dark in new 
24-well plates. After extraction the inserts were pierced with the 
help of a scalpel and the solution was pipetted up and down until 
it appeared homogeneous. After the transfer of two 200-μl ali-
quots of the purple formazan solution into a 96-well flat-bottom 
microtiter plate, the optical density was measured at 560  nm 
against a blank (extractant) solution and calculated as percent tis-
sue viability relative to the untreated negative control, which was 
defined as 100%.
 Statistical Analysis 
 Data are expressed as mean ± standard deviation. Comparisons 
between two different groups were performed by the Mann-Whit-
ney U test, and between more than two groups by nonparametric 
one-way analysis of variance (ANOVA) followed by Bonferroni’s 
multiple comparison test using GraphPad software Prism 5.00 for 
Windows. Results were considered statistically different when p < 
0.05. 
 Results 
 In-House RHE Model 
 RHE equivalents produced from normal adult human 
keratinocytes were used after 14 days of culture at the air-
liquid interface. Histological examinations of hematoxy-
lin and eosin-stained cryosections demonstrated a repro-
ducible epidermis-like structure including a multilayered 
stratum corneum. The stratum corneum was sufficiently 
robust to resist the rapid penetration of the cytotoxic 
marker chemical Triton X-100. The recommended expo-
sure time to reduce cell viability by 50% was greater than 
2 h  [21] . For the negative control OD values were in an 
acceptable range of 0.9–1.3  [22] .
 Measurement of Residual Antimicrobial Effect 
 The log 10 bacterial reduction was assessed after topi-
cally applying 10 6 CFU of test microorganisms to the RHE 
models, which had been pretreated for 15 min with equi-
molar concentrations of either CHG or OCT. The results 
of the quantitative suspension tests for the different incu-
bation times are represented in  figure 1 a–c for  P. aerugi-
nosa and in  figure 2 a, b for  S. aureus . The inactivation 
mixture TSHC was effective for CHG and OCT in the 
presence of  P. aeruginosa and TSLS inactivated both anti-
septic agents in the presence of  S. aureus . After 2 h of in-
cubation, the log 10 reduction was 0.3 for  P. aeruginosa us-
ing OCT pretreated RHE, which was significantly differ-
ent from that of the control and the CHG-RHE, which 
demonstrated low antimicrobial effect ( fig. 1 a). The log 10 
reduction of  P. aeruginosa was increased from 0.8 after 
4 h ( fig. 1 b) to 1.6 after 24 h ( fig. 1 c) incubation utilizing 
CHG pretreated RHE. In contrast, the antiseptic agent 
OCT was significantly more effective on  P. aeruginosa 
than CHG. The log 10 reduction of the OCT pretreated 
RHE was 1.3 after 4 h ( fig. 1 b) and 2.6 after 24 h ( fig. 1 c) 
incubation. Both antiseptically exposed RHE demonstrat-
ed approximately 2-log 10 reduction in the presence of 
 P. aeruginosa,  which parallels with the increase of 2 log 10 
of test microorganisms in the control RHE. S. aureus is 
reduced more effectively by the antiseptically treated RHE 
than  P. aeruginosa . The test microorganism  S. aureus was 
not detectable after 24 h of incubation after contact with 
both CHG- and OCT-RHE, which is equal to a log 10 bac-
terial reduction of more than 5.6 (not shown). After 
15 min of contact, the log 10 reduction was 1.2 for  S. aureus 
utilizing CHG pretreated RHE, which was significantly 
different from that of 3.6 of OCT-RHE ( fig. 2 a). The log 10 
reduction of  S. aureus was scaled up to either 3.3 for CHG-
RHE or 4.2 for OCT-RHE after 4 h incubation ( fig. 2 b).
 Measurement of Viability of Keratinocytes in RHE 
 Viability of keratinocytes in RHE was assessed imme-
diately after testing the microbicidal effect for each ex-
perimental setup. The tissue inserts were subjected to 
MTT assays after thoroughly removing test microorgan-
isms from the RHE. The cytotoxic effect was detected af-
ter either 4 or 24 h for  P. aeruginosa ( fig. 3 ) and either 30 
min or 24 h for tests in the presence of  S. aureus ( fig. 4 ). 
Both after 4 and 24 h the viability of keratinocytes in the 
CHG- and OCT-treated RHE models was significantly 
reduced after testing the microbicidal effect on  P. aerugi-
nosa compared to the control group of unexposed RHE. 
In the presence of bacteria a significant cytotoxic effect 
was only evident after 24 h of contact with RHE water 
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models (viability of 83.5 ± 4.0%) and was enhanced after 
pretreatment of RHE with either CHG (viability of 71.8 ± 
3.8%) or OCT (viability of 74.5 ± 4.5%) using the same 
incubation time with this test microorganism. After 4 h 
of contact with  P. aeruginosa the viability of keratinocytes 
amounted to 91.8 ± 6.2% of that of the control and was 
significantly reduced by about 10% in either CHG-RHE 
equivalents (86.7 ± 12.1%) or OCT pretreated RHE mod-
els (87.6 ± 9.9%) compared with the control group ( fig. 3 ). 
There was no cytotoxic effect evident assessing the viabil-
ity of keratinocytes in RHE after testing the microbicidal 
effect for 30 min in the presence of  S. aureus . After 24 h 
of contact with this microorganism the viability of kera-
tinocytes was significantly decreased in RHE water mod-
els to 80.4 ± 3.2%, and also in RHE equivalents, which had 
been pretreated with either CHG (viability of 64.0 ± 0.9%) 
or OCT (viability of 67.1 ± 2.2%), compared to the control 
group of unexposed RHE ( fig. 4 ). This cytotoxic effect is 
more notable in RHE equivalents following antiseptic 
pretreatment.
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 Fig. 1. Log 10 CFU after 2 ( a ), 4 ( b ), and 
24 h ( c ) incubation of  P. aeruginosa topi-
cally applied on RHE equivalents, which 
had been exposed to water (RHE) or 0.16 
mmol/l of either CHG (RHE-CHG) or 
OCT (RHE-OCT) for 15 min, compared 
with the initial inoculum and controls 
 (medium and inactivator).  *  p < 0.05 com-
pared to the control group (RHE). 
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 Fig. 2. Log 10 CFU after 15 ( a ) and 30 min 
( b ) incubation of  S. aureus topically ap-
plied on RHE equivalents, which had been 
exposed to water (RHE) or 0.16 mmol/l of 
either CHG (RHE-CHG) or OCT (RHE-
OCT) for 15 min, compared to the initial 
inoculum and controls (medium and inac-
tivator).  *  p < 0.05 compared to the control 
group (RHE). 
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* * Fig. 3. Viability of keratinocytes in RHE 
equivalents, which had been exposed to 
water or 0.16 mmol/l of either CHG or 
OCT for 15 min, after testing microbicidal 
effect for either 4 h (n = 8) or 24 h (n = 6) 
with  P. aeruginosa compared to that of un-
exposed negative control (RHE).  *  p < 0.05 
compared to the control group. 
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 Fig. 4. Viability of keratinocytes in RHE 
equivalents, which had been exposed to 
water or 0.16 mmol/l of either CHG or 
OCT for 15 min, after testing microbicidal 
effect for either 30 min (n = 8) or 24 h (n = 
6) with  S. aureus compared to that of unex-
posed negative control (RHE).  *  p < 0.05 
compared to the control group. 
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 Discussion 
 RHE equivalents produced from normal adult human 
keratinocytes were used for the characterization of topi-
cal  adherence of either CHG or OCT. These antiseptic 
agents are frequently used in the medical field, especially 
as skin antiseptic  [23] . Both are cationic antimicrobial 
substances and bind strongly to the cell walls and mem-
branes of bacteria because of their negative charge. The 
outer membrane is destabilized, leading to nonviable cells 
 [24] . The cytotoxic effect of CHG and OCT is also pro-
duced by the interaction with lipophilic substances and 
phospholipids of human and mammalian cell mem-
branes. Therefore, constituents of the cell envelope of 
corneocytes and lipids present in the stratum corneum of 
the epidermis provide potentially binding partners for 
CHG and OCT. Indeed, a residual antimicrobial activity 
was present after topical pretreatment of our in-house 
RHE models with these antiseptic agents ( fig. 1 a–c, 2 a, b). 
This effect was suspected because earlier investigations 
on CHG  [25–27] and OCT  [28] demonstrated a residual 
activity on the skin. In addition, a residual antimicrobial 
effect was also evident in either CHG or OCT cell combi-
nations using murine fibroblasts and human epithelial 
cells  [29] . The microbicidal effect of RHE-associated 
OCT is superior to that of CHG comparing equimolar 
initial concentrations ( fig. 1 a–c,  2 a, b). This result is sup-
ported by others comparing CHG and OCT in different 
antimicrobial tests  [30, 31] . RHE-associated antiseptic 
agents are more effective on  S. aureus  than on  P. aerugi-
nosa . The Gram-positive test microorganism was not de-
tected after 24 h of contact with the antiseptically pre-
treated surface of RHE equivalents. In contrast, the Gram-
negative  P. aeruginosa was only reduced by approximately 
2 log 10 at the same incubation time. In parallel, the initial 
inoculum was also increased by approximately 2 log 10 
( fig. 1 c). These results can be interpreted either as a mi-
crobiostatic effect or as an attachment of  P. aeruginosa to 
the surface of antiseptically pretreated RHE models. An-
timicrobial substances immobilized to surfaces can kill 
bacteria upon contact. For an optimum efficiency of a 
biocidal cationic surface a charge-density threshold must 
be fulfilled  [32, 33] . Too low positively charged stratum 
cornea may be responsible for the attraction and adher-
ence of negatively charged bacteria, only resulting in low 
antimicrobial efficacy, which may be detected by a micro-
biostatic effect. It cannot be excluded that antiseptic treat-
ment of the skin results immediately or at a later point in 
time in a low-density positively charged surface, which 
favors the adherence of negatively charged cellular mate-
rial of bacteria. Low-charge density regions that might 
allow living bacterial cells to adhere can act as a basis 
which may propagate the growth of colonies on top of a 
monolayer of dead cells. This possibility should be further 
evaluated both in vitro and in vivo using normal skin. 
Coating polystyrene of cell culture plates with either 
CHG or OCT in a concentration range of between 5 and 
50 μg/ml demonstrated that OCT prevented adherence of 
 S. aureus  following 48 h of contact but not that of  P. ae-
ruginosa.  In contrast,  CHG-coated polystyrene preferred 
the attachment of both bacteria. Coating concentra-
tions   ≥ 100 μg/ml of CHG prevented the attachment of 
 S. aureus but not that of  P. aeruginosa (unpublished data).
 In general, it is recommended to incubate the RHE 
equivalents for a further 42 h after an exposure period of 
between 15 and 60 min  [8, 22] . The test chemical is con-
sidered to be an irritant to the skin if the tissue viability 
after exposure and posttreatment incubation is  ≤ 50%. 
In  our experiments, the viability of keratinocytes in 
RHE equivalents was assessed immediately after testing 
the antimicrobial efficacy to prevent possibly microbial 
growth. In all tests, the tissue viability was greater than 
50% ( fig. 3 ,  4 ). After 30 min of contact with either  S. au-
reus only or in combination with the antiseptically pre-
treated stratum corneum, the resulting tissue viability 
was not reduced, but a cytotoxic effect was evident after 
24 h of exposure ( fig. 3 ). This parallels with the results in 
the presence of  P. aeruginosa ( fig.  4 ). Pretreatment of 
RHE equivalents with either CHG or OCT increases the 
cytotoxicity after 24 h of incubation compared with that 
of the control with only bacteria, which may be the re-
sult of the penetration of the stratum corneum by small 
amounts of either CHG or OCT. Cytotoxicity of 0.5% 
CHG was also demonstrated using a three-dimensional 
skin model after 10–30 min exposure and 15–18 h post-
treatment incubation  [13] . Other investigations revealed 
minor concentrations of CHG  [34] and OCT  [35] in dif-
ferent layers of the skin. The study on CHG was per-
formed using vertical diffusion cells to evaluate the deliv-
ery of the antiseptic agent through excised full-thickness 
human skin. It was demonstrated that the CHG perme-
ation was not linear. The top layer of the skin (100 μm 
thick) including the stratum corneum (10–20 μm thick) 
and other epidermal layers (50–100 μm thick) contained 
the largest amount of the active agent following 30 min 
exposure to 2% CHG  [34] . The estimated low CHG con-
centration may have produced the minor cytotoxic effect 
on keratinocytes in the RHE model in our study. Diffu-
sion cell experiments were conducted over 28 h for 0.1% 
OCT using intact skin of different animals in vitro. Ap-
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proximately 1–4 μg/cm 2 OCT was found in the stratum 
corneum and the dermis of all split skin samples  [35] . 
These small amounts of OCT can produce cytotoxicity in 
RHE equivalents similar to that of CHG. However, it can-
not be excluded that the viability of keratinocytes in anti-
septically exposed RHE models will be either positively or 
negatively influenced by an elongated incubation period. 
However, both antiseptic agents demonstrated poor per-
meation into the deeper layers of the epidermis. Pretreat-
ment of RHE equivalents with equimolar concentration 
of either CHG or OCT produces a similar tissue viability 
of 65–75%, which can be neglected.
 To assess the suitability of an antiseptic agent, both the 
microbicidal activity and the cytotoxic effect must be tak-
en into consideration to derive biocompatible antibacte-
rial agents  [36] . From the results of the presented study 
the microbicidal effect of OCT is superior to that of the 
RHE-associated CHG comparing the same applied mo-
lar concentrations of active agent. With simultaneous 
consideration of tissue cytotoxicity, OCT applies better 
to the properties of biocompatibility than CHG. How-
ever, further investigations to establish the proper appli-
cation time for antisepsis are warranted.
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